Canine Cancer
AKC Canine Health Foundation Canine Cancer Research
Since 1995, CHF and its donors have funded over $17 million in canine cancer research. These 257 research grants have helped scientists study cancer at the cellular level, providing breakthroughs that allow veterinarians to diagnose cancer earlier and treat it more effectively. CHF-funded research also has a One Health impact, extending beyond dogs with an application to human cancer diagnosis and treatment.
Canine cancer research is a major concern of dog owners and veterinary professionals. Typically, about one quarter of CHF’s grant funding concerns various types of canine cancers.
View our Cancer Research Portfolio
Resources
Canine Cancer Articles
AKC Canine Health Foundation Announces $432,000 Grant to Fight Cancer in Dogs January 6, 2016
The AKC Canine Health Foundation (CHF) is pleased to announce the funding of an exciting grant which aims to better understand and prevent hemangiosarcoma, an aggressive form of cancer in dogs. Together, the American Boxer Charitable Foundation, the Golden Retriever Foundation, and the Portuguese Water Dog Foundation are collaborating by pledging $432,000 to support this research effort.
CHF Featured in WebMD Article on Canine Cancer November 5, 2015
Learn more about how your support of CHF is helping researchers better understand and treat cancer in dogs and humans.
Cancer in Dogs Helps to Inform Human Disease September 18, 2015
AKC Canine Health Foundation contributes funding to research linked to discovering new treatment options to benefit both dogs and humans.
Your Impact: Near-Infrared Fluorescence Imaging Identifies Residual Cancer During Surgery to Remove Sarcomas May 29, 2015
Surgery is the most effective method to treat solid tumors. Local recurrences happen when tumor cells are left in the wound during surgery. Learn how near-infrared (NIR) fluorescence imaging is being used to identify cancer and cancer cells remaining in surgical incisions.
Your Impact: Extending the Lives of Dogs with Melanoma May 22, 2015
Even with aggressive therapy, the median survival time for canine melanoma is less than one year. Learn how your support is making a difference.
Resources Available for Download
Webinars
May 2022 Canine Cancer Webinar Series
Available on a pay per view basis through the AKC Canine College.
Predicting Lymphoma in Dogs, Presented by Dr. Daniel Promislow
Luteinizing Hormone Receptor Activation in Lymphoma and Hemangiosarcoma, Presented by Dr. Michelle Kutzler
Toward Curative Outcomes in Canine Hemangiosarcoma, Presented by Dr. Chand Khanna
LIVE Panel Q&A Session, Presented by Drs. Promislow, Kutzler, and Khanna
A Novel Non-Surgical Option to Preserve Limbs in Canine Osteosarcoma
Original air date: May 25, 2021
Speaker: Joanne Tuohy, DVM, PhD, DACVS
Recent Advances in Cancer Immunotherapy
Original air date: May 2020
Speaker: Steven Dow, DVM, PhD, Diplomate ACVIM (Oncology)
Update on Canine Hemangiosarcoma
Original air date: May 2017
Speaker: Douglas H. Thamm, VMD, DACVIM (Oncology)
Cancer Immunotherapy: Basic Concepts and Strategies for Improving Treatment Outcomes
Original air date: October 2016
Speaker: Douglas H. Thamm, VMD, DACVIM (Oncology)
Lymphoma: The State of This Disease in Dogs and How Epigenetics May Open Future Doors
Original air date: June 2016
Speaker: Jeffrey M. Bryan, DVM, MS, PhD, DACVIM (Oncology)
Podcasts
The Dog Cancer Answers podcast spoke with AKC Chief Veterinary Officer Dr. Jerry Klein about How to Choose a Dog Breeder. Listen for ways to increase the odds of having a healthy puppy, including the importance of AKC Canine Health Foundation funded research.
How You Can Help
Your support means more studies exploring improved diagnostics and new treatment strategies for canine cancer.
Help Future Generations of Dogs
Participate in canine health research by providing samples or by enrolling in a clinical trial. Samples are needed from healthy dogs and dogs affected by specific diseases.
